Description
PCI offers a global network of in-house analytical testing capabilities with laboratories located in North America, Europe, the UK and Asia Pacific, delivering analytical services from the earliest stages of pharmaceutical development through to commercialization, supporting manufacturing, packaging, release and distribution for global supply.
Our analytical services support a wide range of product types including:
High potency
High toxicity
Controlled drugs schedule I-V
Solid, semi-solid and liquid dosage forms
Sterile injectables
Biologic drug products
Medical devices and other drug delivery systems
Respiratory and inhaler systems
Analytical services include:
Method transfer
Method development
Method validation
UPLC method testing
Cleaning verification
Cleaning validation
Raw materials testing
Importation testing
EU release testing
Finished product testing
Routine testing
Mass spectrometry identification
ICH stability storage and testing
Pharmacopeia testing (USP/NF, EP, BP)
Comparator product testing
Clinical and commercial packaging support testing
Micro testing
Stability storage available conditions:
50C
250C/60%RH
300C/65%RH
300C/75%RH
400C/75%RH
-200C
-800C
As an integrated, global CDMO, our in-house analytical testing capabilities provide end-to-end solutions from development to commercialization.